150 related articles for article (PubMed ID: 9778311)
1. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
Roberts ES; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739
[TBL] [Abstract][Full Text] [Related]
3. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
4. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
Moreno RL; Kent UM; Hodge K; Hollenberg PF
Chem Res Toxicol; 1999 Jul; 12(7):582-7. PubMed ID: 10409397
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
7. Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene: the role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
J Pharmacol Exp Ther; 2004 Jul; 310(1):281-90. PubMed ID: 14988423
[TBL] [Abstract][Full Text] [Related]
8. Spectral studies of tert-butyl isothiocyanate-inactivated P450 2E1.
Kent UM; Roberts-Kirchhoff ES; Moon N; Dunham WR; Hollenberg PF
Biochemistry; 2001 Jun; 40(24):7253-61. PubMed ID: 11401573
[TBL] [Abstract][Full Text] [Related]
9. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
10. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1.
Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F
Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
[TBL] [Abstract][Full Text] [Related]
12. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
[TBL] [Abstract][Full Text] [Related]
13. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
14. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of naturally occurring isothiocyanates on the activities of cytochrome P450 2E1 and the mutant P450 2E1 T303A.
Moreno RL; Goosen T; Kent UM; Chung FL; Hollenberg PF
Arch Biochem Biophys; 2001 Jul; 391(1):99-110. PubMed ID: 11414690
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice.
He K; Iyer KR; Hayes RN; Sinz MW; Woolf TF; Hollenberg PF
Chem Res Toxicol; 1998 Apr; 11(4):252-9. PubMed ID: 9548795
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cytochrome P450 2E1 in vivo and in vitro with trans-1,2-dichloroethylene.
Mathews JM; Etheridge AS; Raymer JH; Black SR; Pulliam DW; Bucher JR
Chem Res Toxicol; 1998 Jul; 11(7):778-85. PubMed ID: 9671540
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate.
Kent UM; Yanev S; Hollenberg PF
Chem Res Toxicol; 1999 Apr; 12(4):317-22. PubMed ID: 10207119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
